摘要
1例72岁女性患者,因"慢性咳嗽、咳痰、呼吸困难10年,加重伴间断发热1个月"入院,诊断为慢性支气管炎急性发作,慢性肺源性心脏病,心功能Ⅳ级,双下肢静脉血栓,血小板减少。患者在治疗中需要权衡抗凝药物与促凝药物的应用,在制定方案时利用房颤出血评分系统结合患者临床实际进行出血风险的评估,同时考虑药物之间的相互作用可能对患者产生的危害和用缜密的临床思维来评估患者的预后,减少了患者用药风险。
A 72-year-old female patient was admitted to our hospital due to chronic cough,expectoration and dyspnea for 10 years,aggravated with intermittent fever for 1 month. She was diagnosed as acute exacerbation of chronic bronchitis,chronic pulmonary heart disease,cardiac function class IV,bilateral lower extremity venous thrombosis and thrombocytopenia. The application of anticoagulant drugs and coagulant drugs in the patient needed to be well weighed with the methods of the bleeding score system combined with clinical assessment of actual risk of bleeding. The interactions of drugs harmful to the patient should be considered and the prognosis of the patient should also be evaluated with careful clinical thought to reduce the patient＇s risk.
出处
《中国药师》
CAS
2018年第2期299-301,共3页
China Pharmacist
关键词
深静脉血栓合并出血
抗凝药
促凝药
出血风险
药学监护
Deep venous thrombosis complicated with hemorrhage
Anticoagulants drugs
Coagulant drugs
Bleeding risk
Phar-maceutical care
